Translate to...

China’s Fosun-backed Gland Pharma files papers for Rs 5,000-6,000 crore IPO

China’s Fosun-backed Gland Pharma files papers for Rs 5,000-6,000 crore IPO

China’s Fosun-backed Gland Pharma files papers for Rs 5,000-6,000 crore IPO If the listing plans fructify, this could arguably be the first major domestic IPO of an Indian company with a Chinese parent.